More than 220 organizations, including the AHA, Friday urged Senate committee leaders to consider the Overdose Prevention and Patient Safety Act (H.R. 6082) and encourage Senate leadership to bring the bill to the floor for a vote during the lame-duck session. The House-passed bill would align federal regulations governing the confidentiality of drug and alcohol treatment and prevention records with the Health Insurance Portability and Accountability Act and strengthen consumer protections. “Modifying Part 2 to ensure that HIPAA-covered entities have access to a patient’s medical record will improve patient safety, treatment and outcomes across the care delivery spectrum, enhancing the entire opioid package passed by the House and Senate,” the organizations said in a letter to leaders of the Senate Health, Education, Labor and Pensions Committee.

Headline
The AHA submitted a statement for the record to the House Ways and Means Committee for its April 28 hearing with health system CEOs.In the statement, the AHA…
Headline
The Food and Drug Administration today announced it is accelerating regulatory action on a new class of psychedelic-based therapies, following an April 18…
Headline
The Senate April 23 adopted a budget resolution by a 50-48 vote, paving the way for a narrow reconciliation bill focused on immigration enforcement funding.…
Headline
Americans across 43 states enrolled in health plans from the nation’s four largest commercial health insurers face potential disparities in finding in-network…
Headline
The cigarette smoking rate among U.S. adults dropped to 9.9% in 2024, the lowest level ever recorded, according to a report by the New England Journal of…
Headline
America’s hospitals and health systems are deeply committed to providing high-quality, accessible and affordable care, AHA President and CEO Rick Pollack March…